Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11767334
Heteroaryl inhibitors of PDE4
granted -
US 11759453
SHMT inhibitors
granted -
US 11759461
Small molecule inhibitors of cancer stem cells and mesenchymal cancer types
granted -
US 11759476
Methods of treating metabolic disorders and cardiovascular disease with Inhibin Subunit Beta E (INHBE) inhibitors
granted -
US 11753381
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted -
US 11753366
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 11752138
Treating primary or idiopathic hyperoxaluria with small molecule inhibitors of lactate dehydrogenase
granted -
US 11752195
Compositions and methods of use of synthetic peptides with Mycobacterium abscessus inhibitory activity
granted -
US 11744831
Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
granted -
US 11739086
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
granted -
US 11739093
Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
granted -
US 11739074
Ras inhibitors
granted -
US 11731986
Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof
granted -
US 11732005
Peptidomimetic proteasome inhibitors
granted -
US 11731968
Tricyclic protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
granted -
US 11730720
ALK5 inhibitors
granted -
US 11725008
Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
granted -
US 11718613
N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors
granted -
US 11718612
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted -
US 11718616
JAK kinase inhibitor compounds for treatment of respiratory disease
granted -
US 11718618
Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors
granted -
US 11713313
GLS1 inhibitors for treating disease
granted -
US 11713315
5 to 7 membered heterocyclic amides as JAK inhibitors
granted -
US 11712460
Methods of treating chronic disorders with complement inhibitors
granted